metabolic dysfunction-associated steatotic liver disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning metabolic dysfunction-associated steatotic liver disease
40 articles · page 1 of 4…, monitoring, and treatment needs to be established. Given that MASLD is a multisystem disease, assessing cost effectiveness should c…
…Background Metabolic dysfunction-associated steatotic liver disease and its more severe manifestation, metabolic dysfunction-associ…
…with higher MASLD risk than discordantly high LDL-C, even among T2DM patients with optimal LDL-C and TG levels. Moreover, RC is asso…
…0.049) in covariate-adjusted models, but CIs again spanned 1.0. MASLD was associated with elevated incidence of ACS, AF, and stroke, …
…n (IQR) of 12.5 (11.8–13.2) years, 423 (3.2%) participants with type 2 diabetes and 2758 (0.9%) participants without diabetes developed MALO. P…
…ntly need innovative strategies to combat a growing epidemic of chronic liver disease (CLD). Integrated Diagnostics for Early Detection of Liver Disease (I…
…hitecture, progressing to advanced stages such as cirrhosis and hepatocellular carcinoma, in which the regenerative capacity of the liver is exhausted a…
…Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory progression to metabolic dysfuncti…
…lic dysfunction-associated steatotic liver disease, gallstones, Epstein-Barr virus-induced hepatitis. The remaining four children had blood tests that normalised or…
….Methods This retrospective cohort study included patients with T2DM from Hong Kong (HK-T2DM cohort) and patients with T2DM and meta…
…s.Methods We used UK Biobank data to determine whether incident CVD (the exposure; coronary heart disease [CHD], myocardial infarct…